Prasad’s short FDA tenure brought stricter review standards for gene and COVID vaccines, sparking biotech concern and political backlash.

Vinay Prasad, the top vaccine regulator and chief scientific officer at the Food and Drug Administration (FDA) and a critic of the agency’s COVID-19 policies, has departed after being on the job ...

Other changes under Prasad, who was also the agency's chief medical and science officer, included a new policy limiting the ...

Rare disease and gene therapy stocks, battered in recent months by clinical and commercial setbacks, will likely benefit from ...

Before she became one of the most dynamic voices in international urban planning, Aeshna Prasad was designing immersive ...

The Health and Human Services chief and the growing authoritarianism within the department are already seeding future danger.

Vinay Prasad's interim replacement has concerns about same drug that drove him out. NIH director says employee critics ...

The former official, Vinay Prasad, had been on the job three months and had recently come under attack by conservative ...

A series of recent changes could have significant implications for how Americans receive and pay for their shots.

DIRECTING A CHANGING CDC — The Senate voted to confirm Susan Monarez as the next CDC director Tuesday, marking an end to the ...

F.D.A. resignation: The Food and Drug Administration’s top vaccine and gene therapy official resigned on Tuesday after a ...

A spokesperson for the Department of Health and Human Services confirmed that Dr. Vinay Prasad, who led the FDA’s Center for ...